Follow us on:
Breaking News
July 1, 2026
Breaking News
Breaking News
Featured Pharma Matters Podcast
Lifecore_Podcast_0626_ThisMonth@

From Potential to Practical at DIA 2026: A Three-Part Series on Unlocking AI’s Role in Modern Clinical Trials

 
From Potential to Practical at DIA 2026: A Three-Part Series on Unlocking AI’s Role in Modern Clinical Trials

Reimagining trial design from static protocols to predictive simulation.
Read More >>

Headlines

Breaking News

Lonza Expands HPAPI Capacity in Visp

Will establish new commercial-scale capabilities for the manufacture of complex and highly potent active pharmaceutical ingredients and ADC payload-linkers.

SPONSOR

Smarter Supplier Qualification Starts July 16

Discover how leading pharma teams are lowering risk and quality costs in supplier qualification without sacrificing standards. Free webinar!

Breaking News

Evotec Makes Continuous Manufacturing Technology Available on a Turnkey Basis

J.TRAIN is designed to enable biopharma companies to increase capacity and manufacture biologics at reduced costs and improved productivity.

Breaking News
Collaborations & Alliances

Vect-Horus, Servier Ink CNS Drug Delivery Deal

Partnership will use VECTrans platform to develop targeted oligonucleotide therapies for neurological diseases.

SPONSOR

From Vapor to Value: Mastering Isoprene Manufacturing

In this Pharma Matters Podcast, discover how Valsynthese SA safely manages volatile isoprene chemistry and complex reactions to deliver reproducible results in CDMO manufacturing.

ContractPharma_Conference_2026_650x250

Breaking News
Collaborations & Alliances

Ipsen Acquiring Kartos Therapeutics, Bolstering Late-Stage Cancer Pipeline

Data from an investigational treatment show strong therapeutic potential in intermediate and high-risk myelofibrosis.

Featured Resources

Solution Center SPOTLIGHT

Formulated Solutions

Formulated Solutions is a leading North American CDMO, specializing in Rx, OTC, and medical devices. With 600+ experts and 800,000 sq. ft. across two sites, we develop, manufacture, and package topicals, nasal sprays, liquids, and aerosols. Our proprietary technologies power brands in 40+ countries, delivering innovation at scale since 1999.

 

Solution Center SPOTLIGHT

FAMAR

FAMAR is a leading European CDMO with over 75 years of experience, providing end-to-end solutions for the pharmaceutical and healthcare industries. With 7 manufacturing sites and 2 R&D centers across Germany, Greece, Italy, and Spain, it delivers quality, compliance and value across a broad portfolio of finished dosage forms.